Patient Square Capital LP Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$267.4B
Holdings
20
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (20 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ROIVROIVANT SCIENCES LTD | 12,480,000 | $147.6B | 55.22% | |
| 2 | LQDALIQUIDIA CORPORATION | 1,860,371 | $21.9B | 8.18% | |
| 3 | IM8NINSMED INC | 307,167 | $21.2B | 7.93% | |
| 4 | CGEMCULLINAN THERAPEUTICS INC | 878,897 | $10.7B | 4.00% | |
| 5 | EYPTEYEPOINT PHARMACEUTICALS | 1,410,331 | $10.5B | 3.93% | |
| 6 | NRIXNURIX THERAPEUTICS, INC. | 446,296 | $8.4B | 3.14% | |
| 7 | ITCIEURINTRA-CELLULAR THERAPIES INC. | 71,990 | $6.0B | 2.25% | |
| 8 | ELVNENLIVEN THERAPEUTICS INC | 224,038 | $5.0B | 1.89% | |
| 9 | GONGERON CORPORATION | 1,321,268 | $4.7B | 1.75% | |
| 10 | OCULOCULAR THERAPEUTIX, INC. | 470,919 | $4.0B | 1.50% | |
| 11 | AGIOAGIOS PHARMACEUTICALS, INC. | 121,732 | $4.0B | 1.50% | |
| 12 | PHVSPHARVARIS N V | 207,603 | $4.0B | 1.49% | |
| 13 | IRONDISC MEDICINE, INC. | 56,400 | $3.6B | 1.34% | |
| 14 | SWTXSPRINGWORKS THERAPEUTICS, INC. | 93,137 | $3.4B | 1.26% | |
| 15 | ALLOALLOGENE THERAPEUTICS, INC. | 1,489,909 | $3.2B | 1.19% | |
| 16 | MIRMMIRUM PHARMACEUTICALS, INC. | 64,900 | $2.7B | 1.00% | |
| 17 | NTLAINTELLIA THERAPEUTICS, INC. | 215,981 | $2.5B | 0.94% | |
| 18 | ARVNARVINAS, INC. | 86,627 | $1.7B | 0.62% | |
| 19 | SRRKSCHOLAR ROCK HOLDING CORPORATION | 32,000 | $1.4B | 0.52% | |
| 20 | CATBUSDASTRIA THERAPEUTICS INC | 105,057 | $939.2M | 0.35% |